More evidence has emerged of appalling conflicts of interest that throw
into doubt the advice rendered and the research performed by two
prominent psychiatrists who have received substantial funding from the
Earlier this year, Congressional investigators discovered that Dr.
Joseph Biederman, a world-renowned child psychiatrist at Harvard
Medical School and Massachusetts General Hospital, had failed to report
to Harvard at least $1.4 million in income from drug companies, in
violation of the university’s conflict-of-interest guidelines.
internal drug company e-mail and documents that surfaced in a lawsuit
have sketched out what looks like an unsavory collaboration between Dr.
Biederman and Johnson & Johnson to generate and disseminate data
that would support use of an antipsychotic drug, Risperdal, in
children, a controversial target group.